ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
97,899.29
-0.32%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Upstream Bio Inc (UPB) Cotización

Upstream Bio Inc

Upstream Bio Inc (UPB)

NASDAQ
18.35
2.05
(12.58%)
Cerrado 05 Enero 3:00PM
Delayed by 15 minutes
18.98
0.63
(3.43%)
Fuera de horario: 5:55PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
18.98
Postura de Compra
18.01
Postura de Venta
25.25
Volume Operado de la Acción
269,765
16.045 Rango del Día 18.72
14.97 Rango de 52 semanas 29.30
Precio Anterior
16.30
Precio de Apertura
16.05
Hora
133
@
18.98
(formt)
Última hora de negociación
Volumen promedio (3 m)
367,678
Volumen financiero
US$ 4,780,939
Precio Promedio Ponderado
17.7226

UPB Últimas noticias

Más noticias

Form 4 - Statement of changes in beneficial ownership of securities

17 Diciembre 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

17 Diciembre 2024
Edgar (US Regulatory)

Upstream Bio Appoints Allison Ambrose as General Counsel

WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

17 Diciembre 2024
GlobeNewswire Inc.

Upstream Bio Announces Addition to Russell 2000® Index

WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

16 Diciembre 2024
GlobeNewswire Inc.

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

21 Noviembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 Noviembre 2024
Edgar (US Regulatory)

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...

07 Noviembre 2024
GlobeNewswire Inc.

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

22 Octubre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

15 Octubre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.72-3.6548223350319.720.16815.673121194317.11871018CS
4-3.02-13.72727272732224.97514.9749823317.81728739CS
12-2.52-11.720930232621.529.314.9736767821.10062415CS
26-2.52-11.720930232621.529.314.9736767821.10062415CS
52-2.52-11.720930232621.529.314.9736767821.10062415CS
156-2.52-11.720930232621.529.314.9736767821.10062415CS
260-2.52-11.720930232621.529.314.9736767821.10062415CS

UPB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Upstream Bio?
El precio actual de las acciones de Upstream Bio es US$ 18.98
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Upstream Bio?
Upstream Bio ha negociado en un rango de US$ 14.97 a US$ 29.30 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
US$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
222.72M

Discusión

Ver feed completo
Mr. Bill Mr. Bill 14 minutos hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 16 minutos hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 18 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 19 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 19 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 21 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 22 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 24 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 24 minutos hace
Not good, thanks for sharing.
sand sand 31 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 31 minutos hace
Moving hard soon 
EFSH
mining101 mining101 33 minutos hace
Superb
MEGL
benz280c benz280c 40 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 46 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 47 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 50 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 56 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 56 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hora hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hora hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 1 hora hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD

Su Consulta Reciente

NASDAQ
UPB
Upstream Bio
FX
COPARS
COP vs ARS
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados